Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients (NCT07164352) | Clinical Trial Compass
CompletedNot Applicable
Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients
Turkey (Türkiye)58 participantsStarted 2024-08-04
Plain-language summary
This study aims to evaluate the effects of supervised breathing exercises on pain, dyspnea, and functionality in terminal-stage cancer patients receiving palliative care. Participants in the intervention group receive diaphragmatic and pursed-lip breathing exercises under the guidance of a physiotherapist, while the control group receives only an educational brochure. The study compares pre- and post-intervention outcomes between both groups.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients receiving palliative care, who are part of this treatment process and considered eligible for the study.
* Patients diagnosed with Stage 4 cancer, included in the study due to their advanced cancer stage.
* Patients with oxygen saturation levels below 95% in room air, who are deemed appropriate for monitoring respiratory function due to this condition.
* Participants must be able to effectively communicate during the study period.
* Individuals who agree to participate in the study must provide written or verbal consent, which is a mandatory criterion for ethical compliance.
Exclusion Criteria:
* Patients who are unconscious and unable to participate in the study. Individuals under the age of 18.
* Patients dependent on a ventilator.
* Patients with serious health issues, such as uncontrolled hypertension and dyspnea.
* Patients with other significant health problems that prevent participation in the research program.
* Patients with medical conditions requiring drainage treatment.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
dyspnea
Timeframe: From enrollment to the end of treatment at 1 weeks
2
Functionality
Timeframe: From enrollment to the end of treatment at 1 weeks